The coexistence of a 22.65x EV/EBITDA with a 0.31x P/B suggests the equity is pricing in asset impairment risk rather than operating momentum; investors should not read the low book multiple as conventional value. Because EBITDA is being rebuilt from a low base after ten quarters of losses, the forward EV/EBITDA may compress sharply without any price move, making the trailing multiple look artificially expensive. The 4.8% dividend yield, set against a negative FCF margin of -23.3% in 2026Q2, appears difficult to sustain from internal cash generation and merits monitoring.

The swing in gross margin from 1.6% in 2025Q1 to 37.2% in 2026Q2 alongside a negative operating margin implies that costs outside the gross line — restructuring, depreciation scaled by heavy capex, or stock-based compensation of $16.4 million — are absorbing the gains. Net margin of -68.6% against a positive gross margin means operating leverage at the overhead level has not yet translated into earnings power, so the sustainable metric for this business is likely operating margin excluding non-recurring items rather than net margin. Given accumulated losses of $754.0 million, reported net margin will remain distorted by charges that are not indicative of current unit economics.

An ROIC pinned near zero while total assets more than doubled to $5.7 billion suggests the acquisition-led asset build has not yet produced commensurate operating returns, a pattern that would erode value if persisting. The negative ROE of -17.6% in 2026Q2 versus positive ROE of 19.9% in 2025Q1 appears driven by the loss base rather than equity movements, so ROE should be treated as unreliable for this firm. The decisive driver looks to be efficiency, not margin: with asset turnover at 0.03, even a 37% gross margin cannot generate attractive returns until the asset base is worked harder.

The reduction in D/E from 21.99 to 4.50 alongside a $1.0 billion debt reduction between 2026Q1 and 2026Q2 indicates active deleveraging, but negative interest coverage means the improvement is balance-sheet driven rather than earnings driven. With D/EBITDA at 73.07x in 2026Q1 and no reading for 2026Q2, debt service comfort appears thin relative to peers such as BIP at 1.95x D/E and positive coverage. Investors should watch whether coverage turns positive as EBITDA scales, since covenant headroom, if any, would depend on that inflection rather than on the pace of asset sales.

A current ratio of 0.28 with cash of $172.6 million against $2.9 billion of total debt implies near-term obligations materially exceed liquid resources, and the identical quick ratio confirms the gap cannot be closed through inventory liquidation. The DPO extension from 140 days in 2024Q1 to 189 days in 2026Q2, set against a stable DSO of roughly 46 days, suggests suppliers are effectively financing the working capital gap — a position that may not be sustainable under stress. Under a severe scenario, liquidity would appear to depend on asset disposals or refinancing access, neither of which is confirmed in the supplied data, so the deterioration warrants close monitoring.